Book Value per Share: talphera.com (TLPH)

Graphic logo of Talphera, Inc. (TLPH)

Rigorous FDA audits and patent barriers create a significant entry hurdle for new players. The book value per share of Talphera, Inc. (TLPH) reflects the outcome of implementing high-tech methods for managing hospital pain. Protection against dumping is based on unique analgesic dosage control. Meanwhile, 0.28 serves as the final level marker, capturing the current net asset value of the company per share.

Talphera Inc (TLPH): Share Book Value from 02/21/2024 to 10/26/2026

talphera.com - analytical breakdowns and key metrics (TLPH)

- price and consensus price forecast:
Price Chart Talphera Corp|TLPH - Forecast Levels Chart
- market capitalization data:
Market Capitalization Talphera, Inc.|TLPH - Value Adjusted for Debt and Cash
- book capitalization data:
Net Assets per Single Share Talphera|TLPH - Net Asset Value|Market Capitalization to Book Value Ratio talphera.com|TLPH - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Talphera, Inc.|TLPH - Long-Term Debt to Capital|Short-Term Debt to Equity Talphera|TLPH - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Talphera, Inc.
Fundamental company valuation:Talphera Corp - TLPH
Manufactured products of Talphera

Investors are assessing the market capitalization of Talphera, Inc. (TLPH) through the lens of its development efficiency in the B2B emergency analgesia segment. An analysis of the reported book value per share allows for the tracking of the actual value of net assets on paper, which this chart reflects as the internal financial stability of the biopharmaceutical business and the protection of capital against market volatility.

Competitors of Talphera, Inc. (TLPH)

Net Assets per Single Share Gilead Sciences Inc|CDTX - Share Book Value|Book Value per Share Novavax, Inc. NVAX|CVAC (curevac.com) - Accounting Value of a Share|Net Assets per Single Share Valneva VALN|Share Book Value Vir Biotechnology Inc|SIGA Corp (SIGA) - Book Value per Share|Accounting Value of a Share Emergent Bio (EBS)|Book Value per Share AVIR (Atea Pharmaceuticals)|Invivyd Inc - Book Value per Share|Net Assets per Single Share Enanta Pharmaceuticals, Inc. (ENTA)|INO: Accounting Value of a Share|HLVX (HilleVax Corp) - Net Assets per Single Share|Kalaris Tx (KLRS) - Accounting Value per Share|DYAI (Dyadic International Inc) - Book Value per Share|Book Value per Share NanoViricides Corp (NNVC)|Cocrystal Pharma (COCP) - Accounting Value per Share|Accounting Value of a Share trawspharma.com TRAW|Accounting Value per Share Dogwood Therapeutics DWTX|Net Assets per Single Share Qualigen Corp QLGN|Book Value per Share ALVR (AlloVir Bio)|VBIV: Net Assets per Share|Net Assets per Single Share virios.com VIRI|Accounting Value of a Share Vaxart